Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001493152-24-011836

Chief Executive Officer gave up 6,085 shares (to pay taxes)

  • Chief Executive Officer acquired 20,212 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Alder Matthias Chief Executive Officer 2024-03-26 Option exercise +18,750 25,763 D: show line 1 in the form
Alder Matthias Chief Executive Officer 2024-03-26 Option exercise +825 26,588 D: show line 2 in the form
Alder Matthias Chief Executive Officer 2024-03-26 Option exercise +637 27,225 D: show line 3 in the form
Alder Matthias Chief Executive Officer 2024-03-26 Shares withheld for taxes −6,085 $4.06 $24,705 21,140 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Alder Matthias Chief Executive Officer 2024-03-26 Option exercise · Restricted Stock Units −18,750 56,250 D: show line 5 in the form
Alder Matthias Chief Executive Officer 2024-03-26 Option exercise · Restricted Stock Units −825 8,250 D: show line 6 in the form
Alder Matthias Chief Executive Officer 2024-03-26 Option exercise · Restricted Stock Units −637 6,376 D: show line 7 in the form
Loading xslF345X05/ownership.xml…